trial · primary record
Functional Precision Oncology
Breast Cancer Recurrent
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2028-12-30 |
| Primary endpoint | Proportion of cases where clinically actionable therapies were identified by FPO. |
| Registry ID | NCT05464082 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:26.938Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05464082
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.